Bioline Rx reported $294K in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Arca Biopharma 0 0 Mar/2025
Bio Path 0 0 Mar/2025
Bioline Rx USD 294K 183K Jun/2026
Capricor Therapeutics USD 11.13M 8.87M Dec/2024